Khaled Jabboury Md,pa

["Baylor St. Luke's Medical Center", "HCA Houston Healthcare West", "Houston Methodist Sugar Land Hospital"]

Cell proliferation kinetics of normal and tumour tissue in vitro: quiescent reproductive cells and the cycling reproductive fraction. Baker, F. L., Sanger, L. J., Rodgers, R. W., Jabboury, K., Mangini, O. R. Chemotherapy resistant sarcoma treated with whole body hyperthermia (WBH) combined with 1-3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Joan M C Bull, L. H. Cronau, B. M. Newman, K. Jabboury, S. J. Allen, S. Ohno, T. Smith, A. S. Tonnesen 5-Fluorouracil rechallenge by protracted infusion in refractory breast cancer. Khaled Jabboury, Frankie A. Holmes, Gabriel N. Hortobagyi Phase II evaluation of gallium nitrate by continuous infusion in breast cancer Khaled Jabboury, Debbie Frye, Frankie A. Holmes, Giuseppe Fraschini, Gabriel N. Hortobagyi Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer Richard L. Theriault, Gabriel N. Hortobagyi, Shu W. Kau, Frankie A. Holmes, Verena Hug, Giuseppe Fraschini, Khaled Jabboury, Aman U. Buzdar Percutaneous hepatic arterial infusion of cisplatin-vinblastine for refractory breast carcinoma metastatic to the liver Giuseppe Fraschini, Chusilp Charnsangavej, C. H. Carrasco, Aman U. Buzdar, Khaled Jabboury, Gabriel N. Hortobagyi Evaluation of equipment for hyperthermic treatment of cancer Peter M. Corry, Joseph S. Kong, Elwood P. Armour, Foi J. McCraw, Tam Leduc, Khalid Jabboury Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity. Philip A. Salem, Maryse Khalyl, Khaled W. Jabboury, Labib Hashimi Severe Nephrotoxicity: A Probable Complication of cis-Dichlorodiammineplatinum (II) and Cephalothin-Gentamicin Therapy Philip A. Salem, Khaled W. Jabboury, Maryse F. Khalil